No Image x 0.00 + POST No Image

Matthew McConaughey Turns Trademark Tactics Into a Shield Against AI Copycats

SHARE
0

Hollywood is watching with growing alarm as AI technologies race to replicate actors’ likenesses and voices, with consent rarely guaranteed. For years, actors have rung the alarm bells over the AI industry planning to sell their likeness and voices — either with or without their consent — and hence threatening to put them out of work. Beyond a major 2023 strike by Hollywood actors fueled by these concerns, we’ve already seen actors take matters into their own hands, like when Scarlett Johansson threatened to sue OpenAI over a ChatGPT update that she claims imitated her voice. Two voice actors have also filed a lawsuit, accusing an AI startup of using their voices to train their AI without permission.

Matthew McConaughey Turns Trademark Tactics Into a Shield Against AI Copycats

Tilly Norwood Triggers Backlash as AI Actor Debuts

Tensions came to a head last year when an AI company unveiled an AI actor dubbed Tilly Norwood. The news was met by near-universal backlash from both industry insiders and the public, further stoking fears of the industry coming for human actors’ jobs.

Tilly Norwood Triggers Backlash as AI Actor Debuts

McConaughey’s Trademark Gambit: Eight Applications to Carve a Perimeter

To get ahead of having the industry making unauthorized AI dupes of his likeness or voice, Hollywood star Matthew McConaughey came up with a clever new defense tactic. As the Wall Street Journal reports, the performer filed eight trademark applications to the US Patent and Trademark Office that featured videos and audio clips of him “staring, smiling and talking.” All eight applications have since been approved — and yes, one of the submitted clips included him saying his iconic line, “Alright, alright, alright” from the 1993 movie “Dazed and Confused.” “My team and I want to know that when my voice or likeness is ever used, it’s because I approved and signed off on it,” McConaughey told the newspaper in an email. “We want to create a clear perimeter around ownership with consent and attribution the norm in an AI world.”

McConaughey’s Trademark Gambit: Eight Applications to Carve a Perimeter

A Legal Test Ground The Gambit Aims to Create

The goal is to pave the way for litigation in case a company or individual were to attempt to profit from the actor’s likeness with the help of AI. In a world where we’re watching everybody scramble to figure out what to do about AI misuse, we have a tool now to stop someone in their tracks or take them to federal court, one of McConaughey’s attorneys said.

A Legal Test Ground The Gambit Aims to Create

Copyright Law Still Murky for AI Video Platforms

Copyright law gets murky when it comes to AI-based video platforms like OpenAI’s Sora. The app, which allows users to generate photorealistic clips of famous characters and actors despite the company’s guardrails, was criticized by talent agencies last year. The Sam Altman-led firm appeared to have bungled its messaging at the time, telling some talent agencies at first that they’d have to opt out of having actors they represent appear on Sora — only to change its mind days later, triggering copious confusion.

Copyright Law Still Murky for AI Video Platforms

Unions and Lawmakers Debate Federal Rules for Actor Likeness

Federal rules establishing if, when, and how an actor’s likeness or voice can be used are still being debated by lawmakers. Hollywood unions, however, remain adamant that unauthorized AI clones of actors should be illegal.

Unions and Lawmakers Debate Federal Rules for Actor Likeness

Further Reading: Actors, AI and The New Reality

More on actors and AI: With the Powers of AI, Annoying Dorks Can Now Pretend They’re Friends With Cool Famous People

Further Reading: Actors, AI and The New Reality

About the Author: A Futurism Editor’s Perspective

I’m a senior editor at Futurism, where I edit and write about NASA and the private space sector, as well as topics ranging from SETI and artificial intelligence to tech and medical policy.

About the Author: A Futurism Editor’s Perspective